Filtros de búsqueda

Lista de obras de Melanie White-Koning

Cancer adolescent pathway in France between 1988 and 1997

artículo científico publicado en 2006

Determinants of child-parent agreement in quality-of-life reports: a European study of children with cerebral palsy.

artículo científico publicado en 2007

Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site

artículo científico publicado en 2015

Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents

artículo científico publicado en 2012

Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin.

artículo científico publicado en 2016

Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence.

artículo científico publicado en 2018

Parent and professional reports of the quality of life of children with cerebral palsy and associated intellectual impairment.

artículo científico publicado en 2008

Parent-reported quality of life of children with cerebral palsy in Europe.

artículo científico publicado en 2008

Pharmacokinetic/Pharmacodynamic modeling of abexinostat-induced thrombocytopenia across different patient populations: application for the determination of the maximum tolerated doses in both lymphoma and solid tumour patients

artículo científico publicado en 2014

Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients

scientific article published on 17 April 2019

Plasma cystatin C is a marker of renal glomerular injury in children treated with cisplatin or ifosfamide

artículo científico publicado en 2020

Plasma vemurafenib exposure and pre-treatment hepatocyte growth factor level are two factors contributing to the early peripheral lymphocytes depletion in BRAF-mutated melanoma patients

artículo científico publicado en 2016

Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children.

artículo científico publicado en 2011

Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma.

artículo científico publicado en 2009

Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive su

artículo científico publicado en 2014

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.

artículo científico publicado en 2013

Prevalence and Associated Factors of Minor Neuromotor Dysfunctions at Age 5 Years in Prematurely Born Children

scientific article published on 01 November 2007

Psychological problems in children with cerebral palsy: a cross-sectional European study

artículo científico publicado en 2007

Psychological problems in children with hemiplegia: a European multicentre survey

artículo científico publicado en 2009

Reliability and validity of the Child Health QuestionnairePF-50 for European children with cerebral palsy

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda